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In Brief
Wiegreffe et al. discover a novel Bcl11a/ Sema3c-dependent regulatory pathway that controls polarization and radial migration of late-born upper layer cortical projection neurons. Deletion of Bcl11a in mice ultimately results in severe hypoplasia of upper neocortical layers.
INTRODUCTION
The neocortex plays a major role in cognitive, emotional, and sensory-motor functions. All parts of the neocortex have a common principle structure, with neurons organized in six horizontal layers, oriented parallel to the brain surface (Kwan et al., 2012) . During development of the neocortex, progenitor cells located in the dorsal wall of the lateral ventricle give rise to immature projection neurons that migrate radially toward the pial surface and acquire a layer-specific neuronal identity. While early-born neurons populate the deep cortical layers, late-born neurons migrate past the deep cortical layers to settle in the upper cortical layers. After being generated in the ventricular and subventricular zones (VZ/SVZ), postmitotic neurons become transiently multipolar, slow their migration, and explore the environment for signals required for further development. After a short stay in the intermediate zone (IZ), prospective cortical projection neurons switch to a bipolar morphology, attach to the radial glial scaffold, and initiate radial migration into the cortical plate (CP) (LoTurco and Bai, 2006; Noctor et al., 2004; Tabata and Nakajima, 2003) . Upon reaching their destined target layers cortical neurons detach from radial glial fibers and undergo layer typespecific terminal differentiation. Mutations affecting different steps of neuronal migration lead to severe cortical malformations, such as lissencephaly or white matter heterotopias (Evsyukova et al., 2013) .
The migration of cortical projection neurons is regulated on several levels: (1) by genes such as Lis1, Ndel1, or Dcx, involved in the direct control of cell motility and the modulation of cytoskeletal dynamics, (2) by cell-type-specific transcriptional programs, and (3) by extracellular signals, providing instructive cues to migrating neurons (Evsyukova et al., 2013; Kwan et al., 2012) . For example, the transcription factors Satb2, Pou3f2 (Brn2), and Pou3f3 (Brn1) are enriched in upper-layer cortical neurons, and their genetic ablation in mice results in aberrant specification and migration of late-born neurons (Alcamo et al., 2008; Britanova et al., 2008; Kwan et al., 2012; McEvilly et al., 2002; Sugitani et al., 2002) . The signals acting downstream of transcriptional regulators that control cortical neuron migration are incompletely defined. Various members of class III semaphorins are present along the migratory route of cortical projection neurons, and their cognate receptors of the neuropilin and plexin families are expressed by migrating cortical neurons. Functional studies suggest that class III semaphorins provide guidance cues to migrating cortical neurons (Chen et al., 2008; Ito et al., 2008; Marín et al., 2001; Tamamaki et al., 2003) .
Bcl11a (Ctip1) encodes a zinc-finger protein that regulates transcription through interaction with COUP-TF proteins, as well as direct, sequence-dependent DNA binding (Avram et al., 2002; John et al., 2012) . We recently demonstrated that Bcl11a is essential for morphogenesis and wiring of projection neurons in the dorsal spinal cord (John et al., 2012) . Bcl11a is also expressed in the developing murine neocortex (Leid et al., 2004) .
Several studies in humans strongly suggest that BCL11a is a candidate gene for the 2p15-16.1 microdeletion syndrome, which is associated with neocortical dysplasia and mental retardation (Basak et al., 2015; Hancarova et al., 2013; Peter et al., 2014; Rajcan-Separovic et al., 2007) . Here, we provide evidence that Bcl11a is essential for neocortical development. Bcl11a mutant late-born cortical neurons are impaired to switch from multipolar to bipolar morphology and fail to migrate, resulting in delayed arrival at their final destination. Postmigratory neocortical neurons require early, but not late, expression of Bcl11a for their morphogenesis and survival. Finally, we identify Sema3c as a direct Bcl11a target gene that controls cortical projection neuron polarization and migration. Taken together, in this study, we identify a novel Bcl11a/Sema3c-dependent regulatory pathway controlling migration of cortical projection neurons.
RESULTS

Bcl11a Is Expressed in Young Neocortical Neurons
During cortex development, Bcl11a protein expression is restricted to projection neurons and some GABAergic interneurons, but is excluded from proliferating progenitors of the VZ/SVZ or from glia ( Figures 1A, 1B , and 1F). At postnatal day 2 (P2), at which time most migrating cortical projection neurons reached their designated layers, we noted that Bcl11a protein expression overlaps with the expression of Cux1 (Nieto et al., 2004) and Brn2 (McEvilly et al., 2002; Sugitani et al., 2002) , both identifying late-born upper-layer projection neuron populations ( Figure 1E ). At P2, Bcl11a expression was also detected in Brn2/Cux1-negative deep-layer neurons ( Figure 1E ). Between E13.5 and 15.5, during which time migrating cortical neurons leave the Unc5d and Neurod1-positive SVZ/IZ (Mattar et al., 2008; Sasaki et al., 2008) , we found co-localization of both markers with Bcl11a, most prominently in the upper IZ ( Figures  1C and 1D ).
Late-Born Cortical Neurons Require Bcl11a for Migration
To study the functions of Bcl11a in cortical development, we generated a conditional mouse model. Homozygous recombination of a Bcl11a flox allele (John et al., 2012) in either cortical progenitor cells (Bcl11arEmx1 Cre mutant) or postmitotic projection neurons (Bcl11arNex
Cre mutant) resulted in effective ablation of Bcl11a protein (Figures S1A and S1B). Bcl11a ablation caused a marked reduction of cortical thickness and layer disorganization, while at P2 the total number of neurons remained unchanged (Figures S1C-S1F). Next, we analyzed the proliferation and survival of Bcl11arEmx1 Cre mutant neurons. At E14.5 and E16.5, the number of proliferating progenitor cells, as identified by incorporation of bromodeoxyuridine (BrdU), and the simultaneous expression of Pax6 and Tbr2 were found to be unchanged in mutants compared to controls ( Figures  S2A-S2H ). Furthermore, we did not detect differences in the numbers of cleaved Caspase3-positive cells in the neocortex of mutant and control brains from E14.5 to P2 (Figures S2I-S2K ). This excludes changes in neurogenesis and/or survival to contribute to the observed phenotype in the Bcl11a mutant neocortex. The onset of Bcl11a expression was detected within the IZ ( Figures 1A-1D ), where cortical neurons undergo polarity changes required for initiation of radial migration (Cooper, 2014) . This prompted us to analyze the migration process of upper-layer cortical neurons in greater detail. We used in utero electroporation (IUE) to directly examine whether Bcl11a is cell-intrinsically required for migration of prospective late-born (i.e., E14.5-E15.5), upper-layer neurons. A vector containing Cre, followed by a cytoplasmically expressed IRES-GFP cassette, was introduced into the lateral VZ of Bcl11a flox/flox and Bcl11a flox/+ embryos at E14.5, resulting in the efficient and specific deletion of Bcl11a in electroporated cells (Figures S3A and S3B) . Electroporated brains were analyzed on consecutive time points from E16.5, after electroporated neurons left the progenitor zone entering the SVZ/IZ, to P2, when most of the cells reached their target sites (Figures 2A-2D ). At E16.5, no difference in the distribution of GFP-expressing cells was detected (Figures 2A and 2E) . However, at E17.5, significantly fewer GFP-positive Bcl11a mutant cells were located in the CP, and more cells were found in the IZ, as well as in the VZ/SVZ compared to controls (Figures 2B and 2F) . A similar shift in distribution was still detectable at E18.5 ( Figures 2C and 2G ), while at P2 the relative number of GFP-positive cells found in mutants was normalized. At this stage, we also noted that mutant cells were packed more densely in bin 1 (corresponding to layers 2-3) as compared to controls ( Figures 2D and 2H Figures S5A and S5B ). Co-electroporation of Cre-IRES-GFP, together with a vector containing Bcl11a-XL cDNA, was sufficient to completely normalize the ratio of multi-to bipolar morphologies ( Figures 3A-3C ). To further characterize polarization in Bcl11a mutant cortical neurons, we labeled the Golgi apparatus with GFP-tagged galactosyltransferase (Jossin and Cooper, 2011; Yanagida et al., 2012) and quantified the proportion of Bcl11a mutant and control cells with the Golgi apparatus facing the CP ( Figure 3D ). Loss of Bcl11a resulted in a significant decrease of cells with a radially oriented Golgi apparatus already at E16.5 ( Figures 3D and 3E) , supporting a role of Bcl11a in cortical neuron polarization.
To test whether changes in the organization of the radial glial scaffold contribute to the defective neuronal migration, we used nestin as a marker. Radial glial scaffold was unchanged in Bcl11arEmx1
Cre mutants compared to controls (Figures S2L and S2M) .
To directly visualize the migratory behavior of late-born cortical neurons, we carried out live-cell imaging studies using cultured slices from Bcl11a flox/flox brains electroporated with either Cre-IRES-GFP or a control vector (Figure 4 ; Movies S1, S2, and S3). Together, these experiments confirmed that Bcl11a mutant cortical neurons fail to efficiently switch from multi-to bipolar morphology and to properly continue radially oriented migration ( Figure 4A ; Movies S1, S2, and S3). This results in significantly reduced overall migration speed and a characteristic shift in the speed profiles, as well as in the radial orientation of mutant neurons as compared to controls ( Figures  4B-4E ). Interestingly, analysis of individual migration profiles revealed that Bcl11a mutant neurons frequently undergo repetitive phases of several hours duration with dramatically reduced speed and random-like orientation changes ( Figure 4B ; Movie S3).
Sema3c Acts Downstream of Bcl11a to Control Bipolar Morphology and Radial Migration
To identify candidate molecules acting downstream of Bcl11a, we performed microarray-based gene expression profiling at E14.5 using cortical tissue from Bcl11a mutant and control littermates. Based on this analysis, Sema3c was consistently found deregulated in Bcl11a mutants (Table S1 ). Verification by quantitative real-time PCR revealed a 2.8-fold upregulation of Sema3c at E14.5 and E16.5 ( Figure 5A ). In situ hybridization showed changes in the expression pattern of Sema3c, which was increased in the SVZ/IZ of the Bcl11arEmx1 Cre neocortex at both stages ( Figure 5B ). Using the Ensembl Genome Browser (Flicek et al., 2013) , we identified a putative regulatory region of 1.1 kb in the second intron that was located 35 kb downstream of the transcriptional start site of Sema3c and contained six GGCCGG motifs that are known binding sites of Bcl11a (Avram et al., 2002) and are separated from each other by 212 bp. The motifs were located in six larger DNA repeats with a high degree of conservation. Binding of Bcl11a to these repeats was tested by chromatin immunoprecipitation (ChIP), followed by quantitative real-time PCR using a primer pair that specifically detected binding to all six motifs. An enrichment of precipitated DNA of more than 4-fold was found using a Bcl11a-specific antibody in comparison to an immunoglobulin G (IgG) control antibody ( Figure 5C ), demonstrating binding of Bcl11a to this region. As a negative control, binding of Bcl11a to the Hprt promoter was tested, but no significant enrichment was found in comparison to the IgG control antibody ( Figure 5C ). This 1.1-kb regulatory sequence was tested for transcriptional activity by luciferase assays, and a repression of 31% was measured, indicating this element to convey functional repression through Bcl11a binding ( Figure 5D ). Consistent with the biochemical analysis, Sema3c gene expression and Bcl11a protein expression overlap in the IZ of the neocortex ( Figure 5E ). Moreover, the Sema3c receptors Nrp1 and Plxna2 are as well expressed in the IZ (Chen et al., 2008; Hatanaka et al., 2009 ). Electroporation of a vector containing Sema3c cDNA, followed by an IRES-GFP cassette into the VZ of E14.5 wild-type embryos, resulted in migration defects of cortical neurons similar to those observed upon loss of Bcl11a ( Figures 5F and 5G ). In addition, the proportion of multipolar cells was significantly increased upon overexpression of Sema3c in comparison to control vector ( Figure 5H ). Finally, using GFP-tagged galactosyltransferase demonstrated a similar decrease in the proportion of cells with the Golgi apparatus facing the CP in both neurons with gain of function of Sema3c and with loss of Bcl11a (Figures 5I and 5J ; cf. Figures  3D and 3E ). Next, we performed genetic rescue experiments by introducing two independent Sema3c short hairpin RNA (shRNA) constructs into Bcl11a-deficient cells. Compared to a control shRNA, both constructs knocked down Sema3c expression but to various extents (shRNA#2 > shRNA#1) in HEK293 cells ( Figure 6D , left). Each construct was co-electroporated with Cre-IRES-GFP into the VZ of Bcl11a flox/flox embryos at E14.5. Remarkably, knockdown of Sema3c by shRNA#2 completely rescued neuronal migration and morphological defects in Bcl11a mutant neurons, while we still observed partial rescue of the phenotype with the less-efficient shRNA#1 ( Figures  6A-6C ). As a further control, we electroporated shRNA#1 or #2, together with a knockdown-resistant Sema3c* cDNA ( Figure 6D , right) into Bcl11a mutant neurons. By this, we were not able to rescue the Bcl11a mutant phenotype (Figures 6A-6C ). Altogether, our data provide evidence that Sema3c is an important downstream effector of Bcl11a, regulating polarization and radial migration of cortical neurons.
Morphogenesis and Survival of Postmigratory Upper Layer Neurons Depend on Bcl11a
Impaired migration of Bcl11a mutant cortical neurons resulted in delayed arrival and higher compaction of neurons within the CP ( Figure 2D ), raising the possibility that morphogenesis of postmigratory upper layer neurons might also depend on Bcl11a. To directly visualize the morphology of single neurons within the upper cortical layers, we co-electroporated Bcl11arEmx1
Cre brains at E14.5 with a FLPe expression construct at low concentration, together with a FLPe-dependent GFP reporter (Matsuda and Cepko, 2007) . Compared to controls at P2, late-born Bcl11a mutant neurons displayed severe changes in their morphology as characterized by dramatically shortened primary apical dendrites and increased dendritic branching close to the soma ( Figures 7A-7C ). Next, we asked whether impaired morphology of mutant upper-layer neurons is due to an isolated, postmigratory function of Bcl11a or whether morphogenesis requires early expression of this factor. Using a tamoxifen-dependent ERT2-Cre-ERT2 construct (Matsuda and Cepko, 2007) , we selectively induced the mutation of Bcl11a after E18.5 when the majority of neurons had reached the superficial CP ( Figure S6 ) and found that the morphology of the Bcl11a mutant upper-layer cortical neurons was unchanged ( Figures  7D-7F ). To explore, whether impaired morphogenesis of neurons with an early mutation of Bcl11a is part of a specification defect, we analyzed molecular markers expressed by late-born upper-layer neurons. At P2, the proportion of lateborn neurons, as identified by BrdU injection at E15.5, that co-expressed Cux1, Brn2, or Satb2 was unchanged in Bcl11arEmx1
Cre mutants compared to controls (Figures S7A-S7C and S7F), suggesting that late-born Bcl11a mutant neurons retain their capacity to undergo normal upper-layer specification as defined by these markers.
To analyze whether these neurons are subsequently depleted by apoptosis, we quantified cleaved Caspase3 expression in Bcl11arEmx1
Cre mutant brains and found a massive increase of apoptosis in superficial cortical layers from P4 to P6 ( Figures  7G-7H ). In addition, we noticed a discrete elevation of cell death in deep cortical positions between P4 and P5. Electroporation of Bcl11a flox/flox brains with Cre-IRES-GFP at E14.5 increased the apoptosis rate selectively in late-born GFP-positive Bcl11a mutant cells at P5 (Figures 7I and 7J ). Compared to controls, apoptosis rates remained unchanged at P5, when the Bcl11a mutation was selectively induced by tamoxifen after E18.5 ( Figures 7K and 7L) . At P8, the number of Cux1-and Brn2-expressing neurons within the upper layers was dramatically reduced, and the thickness of the corpus callosum, which harbors axonal projections predominantly derived from upperlayer neurons, was significantly narrowed in Bcl11arEmx1
Cre mutants ( Figures S7H-S7K) . Collectively, our data suggest that late differentiation, as characterized by altered morphology, and the subsequent survival of postmigratory upperlayer neurons, depend on the early expression of Bcl11a and may thus be the consequence of impaired migration and delayed arrival of neurons.
Interestingly, morphology and survival of upper-layer cortical neurons were unchanged at P2 and P5, respectively, in wild-type brains electroporated with Sema3c-IRES-GFP at E14.5 (data not shown). Thus, the late phenotype of Bcl11a mutant upper-layer neurons appears to be independent of Sema3c. brains electroporated at E14.5 with Cre-IRES-GFP or a control vector (n = 15). Mean ± SEM; Student's t test; ***p < 0.001. Scale bar, 10 mm. See also Movies S1, S2, and S3.
A Function of Bcl11a in Deep-Layer Neuron Specification
We noticed that BrdU injection at E15.5 labeled small amounts of cells in control brains still expressing Tbr1 and Bcl11b, which label deep-layer neurons predominantly born at earlier stages (Molyneaux et al., 2007) . In Bcl11arEmx1 Cre mutants a small increase in the proportion of Bcl11b-positive cells, but no change in Tbr1 expression, was detected ( Figures S7D, S7E , and S7G), raising the possibility that Bcl11a exerts additional functions in the specification of a part of deep-layer neurons. Indeed, when we tagged early-born deep-layer neurons by BrdU-injection at E12.5, we found an increase in the proportion of Bcl11b co-expressing cells at the expense of those neurons co-expressing Tbr1 or Fog2 ( Figures 8A-8C Figures S8A and S8B ).
In addition, we analyzed 10-week-old Bcl11arEmx1 Cre mutants crossed to Thy1-YFP transgenic mice expressing YFP, specifically in layer 5 (i.e., Bcl11b-positive) neurons, and the corresponding corticospinal tract (Feng et al., 2000) . Surprisingly, none of these experiments revealed major alterations in deeplayer neuron projections ( Figures S8C and S8D ). (legend continued on next page)
DISCUSSION
In this study we provide direct genetic evidence that the transcription factor Bcl11a is required for cell-polarity switch and radial migration of upper-layer projection neurons. We show that Bcl11a acts through direct transcriptional regulation of Sema3c in this process. Sema3c is expressed by migrating neurons in the IZ of the neocortex. Overexpression of Sema3c in wild-type cortical neurons recapitulates the Bcl11a mutant phenotype, whereas knockdown of Sema3c in Bcl11a-deficient cortical neurons rescues it. Moreover, early expression of Bcl11a is required for late differentiation and survival of upper-layer cortical neurons independent of Sema3c. Migrating upper-layer neurons become transiently multipolar in the SVZ and lower IZ and move randomly for a limited period of time. Subsequently, they extend axons, orient themselves toward the pia, and become bipolar in the upper IZ (LoTurco and Bai, 2006; Namba et al., 2014; Noctor et al., 2004; Tabata and Nakajima, 2003) . This polarity switch is an important step during radial migration that has been implicated in specification of neuron subtype identity, cortical lamination, and projection formation (Evsyukova et al., 2013; Miyoshi and Fishell, 2012; Noctor et al., 2004; Ohshima et al., 2007; Pacary et al., 2011) . Loss of function of Bcl11a in late-born migrating upper-layer neurons increased the proportion of neurons with retained multipolar morphology at the expense of bipolar cells, specifically in the lower and middle IZ. Impaired polarization precedes misdistribution of mutant migrating neurons. This suggests that Bcl11a-deficient neurons fail to switch to a bipolar morphology and to properly continue radial migration. Using live-cell imaging analyses, we directly demonstrate that appropriate polarization and radial migration depend on Bcl11a.
Bcl11a mutant neurons repetitively slowed migration and randomly changed their orientation for a prolonged time, suggesting that these cells unsuccessfully probe the environment for signals regulating their migration. Compatible with this, we identified an extracellular guidance molecule, Sema3c, as a critical component required for radial migration. Sema3c and Bcl11a co-localize in neurons within the IZ, and Bcl11a directly binds to a regulatory element in the second intron of the Sema3c gene that conveys transcriptional repression. In Bcl11arEmx1 Cre mutants, Sema3c was upregulated in the SVZ/IZ, and the fraction of multipolar cells was increased upon loss of function of Bcl11a or gain of function of Sema3c. Moreover, knockdown of Sema3c in Bcl11a mutant neurons was sufficient to completely rescue impaired polarization and migration, indicating that Sema3c regulates radial migration downstream of Bcl11a. This does, however, not exclude additional downstream targets of Bcl11a from being involved in this process.
Another class III semaphorin, Sema3a, functions as a polarizing factor in cortical neurons by suppressing axon formation and promoting dendrite growth (Shelly et al., 2011) . In addition, Sema3a orients apical dendrites of cortical neurons toward the pial surface and guides their migration (Chen et al., 2008; Polleux et al., 2000) . In contrast, Sema3c has been shown to act as an attracting factor for neocortical axons, both in vitro and in vivo (Bagnard et al., 1998 (Bagnard et al., , 2000 Niquille et al., 2009; Piper et al., 2009) . Because all class III semaphorins bind to Nrp1/2 receptors (Pasterkamp, 2012) , which are expressed in migrating neocortical neurons (Chen et al., 2008; Hatanaka et al., 2009) , increased levels of Sema3c in Bcl11a mutants might oppose the Sema3a signal that guides migrating neurons toward the pial surface. Thus, our analysis suggests a mechanistic concept, by which combinatorial codes of different semaphorins may exist in the wild-type neocortex controlling morphology and migration of projection neurons.
Previous studies suggest that neuronal migration and laminar identity are co-regulated by the same transcriptional programs in developing cortical projection neurons (Evsyukova et al., 2013; Kwan et al., 2012) . In Satb2 mutants, for example, upper-layer neurons show a defect in migration that is corrected within the first postnatal week. Upper-layer neurons ectopically activate Bcl11b expression (which is normally restricted to L5) and adapt to their abnormal environment by projecting aberrantly into the corticospinal tract (Alcamo et al., 2008; Britanova et al., 2008) . Although, Bcl11a-deficient late-born neurons retained their endogenous marker profile (Satb2, Cux1, and Brn2), we observed striking alterations in neuron morphology after delayed arrival at their target sites. Subsequently, a part of the mutant neurons is eliminated by apoptosis. This ultimately results in hypoplasia of the upper cortical layers and of the callosal tract. Interestingly, postnatal morphogenesis and survival of upperlayer neurons requires the early expression of Bcl11a. However, these processes do not depend on Sema3c signals. Thus, Bcl11a appears to regulate distinct steps during the development of late-born upper-layer neurons through separate downstream pathways. Several scenarios may explain why Bcl11a mutant neurons die postnatally. Altered morphology may prevent mutant neurons from synaptic integration into the cortical circuitry; as a consequence, non-functional neurons are depleted by apoptosis (Verhage et al., 2000) . Moreover, delayed arriving Bcl11a mutant upper-layer neurons may miss spatiotemporally limited signals, provided by the target zone, that are required for further maturation, as well as for proper functional integration. Alternatively, Bcl11a might control the expression of signals that provide trophic support to upper-layer neurons. In line with this, Bcl11a has been shown in other tissues to directly regulate apoptosis pathways, including members of the anti-apoptotic Bcl2 family (Yu et al., 2012) . Interestingly, the mutation of Bcl-xL in mice results in massive cell death of cortical neurons (Motoyama et al., 1995; Zaidi et al., 2001) . Moreover, Rho GTPases have been shown to control cytoskeletal dynamics (Luo, 2000) , as well as survival of cortical neurons (Sanno et al., 2010) . Thus, Bcl11a-dependent signals regulating morphology and survival of cortical neurons may exist that converge at the level of the cytoskeleton.
(D) Western blot analysis of HEK293 cells co-transfected as indicated and probed using anti-Sema3c and anti-b-Actin antibodies. Sema3c shRNA#1 and #2 reduce Sema3c expression to a different extent (shRNA#1 < shRNA#2) 2 days after transfection. Sema3c* is not reduced by Sema3c shRNA#1 or #2. All graphs represent the mean ± SEM; one-way ANOVA, followed by an LSD post hoc test; ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001. Scale bars, 50 mm. 
(legend continued on next page)
Our analysis of the function of Bcl11a in neocortical development uncovered an additional independent role of this factor in deep-layer neuron specification, resulting in a loss of Tbr1-and Fog2-positive layer 6 neurons and a simultaneous increase in Bcl11b-positive layer 5 neurons. The increased number of Bcl11b-positive neurons might be caused by compensatory upregulation of this closely related gene. Upregulation of Bcl11b could be responsible for Tbr1 repression in the deep cortical layers of the Bcl11a mutants; such a mechanism was previously observed in Satb2 mutants that show upregulation of Bcl11b as well (Srinivasan et al., 2012) . At P2, we did not detect changes in the distribution of deep-layer neurons within the CP. This does, however, not exclude transient defects in migration of this neuron population. Moreover, we observed a mild increase in apoptosis within the deep cortical layers at P4-P5. This raises the possibility that Bcl11a might have a uniform function in both deep-upper-layer cortical neurons. Experimental evidence provided in this study argues against such a model: loss of Bcl11a results in (1) altered specification of deep-but not of upper-layer neurons and (2) substantial and lasting defects of major projections of upper-layer (reduced size of corpus callosum), but not of deep-layer, neurons (unchanged corticospinal and corticothalamic tracts).
Recently, a genome-wide association study (GWAS) and whole-exome sequencing have identified Bcl11a as a candidate gene involved in developmental disorders, including autism spectrum disorders associated with impaired neocortical development (De Rubeis et al., 2014; Deciphering Developmental Disorders, 2015; Hussman et al., 2011; Iossifov et al., 2012) . Moreover, Bcl11a is a candidate for the 2p15-16.1 microdeletion syndrome, which is associated with mental retardation and neocortical dysplasia (Hancarova et al., 2013; Peter et al., 2014; Rajcan-Separovic et al., 2007) . Our study provides direct genetic evidence for Bcl11a as an essential regulator in the development of the neocortex in mice and thus further establishes an important role for this gene in the pathophysiology of neurodevelopmental disorders in humans.
EXPERIMENTAL PROCEDURES
Mouse Mutants, BrdU, and Tamoxifen Injection All mouse experiments were carried out in compliance with German law and approved by the respective government offices in Tü bingen. Mice carrying a conditional knockout allele of Bcl11a (Bcl11a flox ) have previously been described (John et al., 2012) . These mice were crossed to Deleter Cre ,
Emx1
IRESCre , or Nex Cre mice (Goebbels et al., 2006; Gorski et al., 2002; Schwenk et al., 1995) ; Nex Cre/+ littermates served as controls. Genotyping of the mice was performed by PCR. For BrdU birth dating experiments, BrdU (50 mg/kg of body weight) was intraperitoneally injected at E12.5, E14.5, E15.5, and E16.5, and embryos were dissected after 1 hr (for proliferation experiments) or at P2 (for pulse-chase and fate experiments). Tamoxifen (100 mg/kg of body weight) was injected intraperitoneally at E18.5.
Histology, Immunohistochemistry, and In Situ Hybridization Histology, immunohistochemistry, and in situ hybridization were performed as previously described (John et al., 2012; Simon et al., 2012) . Additional information is in the Supplemental Experimental Procedures.
Plasmids
Plasmids used in this study are listed in the Supplemental Experimental Procedures.
In Utero Electroporation
In utero electroporation was performed as previously described (Saito and Nakatsuji, 2001 ). Additional information is in the Supplemental Experimental Procedures.
Slice Culture and Live Imaging
Slice culture was performed as previously described (Polleux and Ghosh, 2002) . Movies were analyzed using the ImageJ (v1.48, RRID: nif-0000-30467) (NIH) software. Additional information is in the Supplemental Experimental Procedures.
Microarray Analysis
Microarray analysis was performed as previously described (John et al., 2012; Simon et al., 2012 (K) The proportion of cleaved Casp3-positive cells co-expressing GFP at P5 is unchanged upon electroporation of ERT2-Cre-ERT2, together with loxP-GFP into Bcl11a flox/flox brains at E14.5, followed by injection of tamoxifen at E18.5 compared to a control vector.
(L) Quantification of the experiment shown in (K) (n = 3). All graphs represent the mean ± SEM; Student's t test; ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001. Scale bars, 100 mm (A and D) , 500 mm (G), and 50 mm (I and K). See also Figure S7 . The relative copy number of Gapdh RNA was quantified and used for normalization. Data were analyzed using the comparative C T method (Schmittgen and Livak, 2008) .
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assays were carried out as previously described . Briefly, ChIP assays were performed on cortical tissue collected from ten wild-type embryos at E14.5 employing a specific mouse monoclonal antibody recognizing Bcl11a (Abcam Cat# ab19489, RRID: AB_2063996) and using the EpiQuick Tissue Chromatin Immunoprecipitation Kit (Epigentek), including mouse IgG as a non-specific control. The precipitated DNA was analyzed by quantitative real-time PCR using oligonucleotides recognizing a 1.1-kb region in the second intron of Sema3c: 5 0 -GCGCCAGAGAACCTGACA-3 0 and 5 0 -CTGCTGCTGTGGCTTAGG-3 0 . As a negative control, the Hprt promoter region was used, which was recognized by the following oligonucleotides: 5 0 -CTGCCTCTGCCTCCTAAATG-3 0 and 5 0 -TGTCGTCTCCCAGAGGATTC-3 0 . ChIP quantitative real-time PCR data were analyzed by the comparative C T method determining the fold enrichment of the immunoprecipitated DNA by the specific antibody versus IgG using the input DNA as reference. C T values > 35 were disregarded. Every ChIP experiment was repeated at least three times.
Luciferase Assay The 1.1-kb region in the second intron of Sema3c was cloned into the pMCSGaussia Luc Vector (pMCS-GLuc; ThermoScientific). This construct was transfected into HEK293 cells with and without pCMV-Myc-Bcl11a-XL using Lipofectamine 2000 in accordance with the manufacturer's instructions (Invitrogen). Empty pMCS-GLuc plasmid with or without pCMV-Myc-Bcl11a-XL was transfected as a control. pCMV-SEAP (secreted alkaline phosphatase) was co-transfected in each well as a transfection control. Supernatant from All graphs represent the mean ± SEM; Student's t test; *p < 0.05; **p < 0.01; ***p < 0.001. Scale bars, 50 mm. See also Figure S8 .
transfected cells was analyzed 48 hr after transfection. Luciferase assays were performed using the Secreted Pair Dual Luminesence Assay Kit (Genecopoeia) in accordance with the manufacturer's instructions and GloMax microplate luminometer (Promega). The values are reported as the mean ratio of luminescence intensity (RLU) of Gluc over SEAP. Values were collected from three independent experiments performed with at least three replicates per experiment.
Cell Culture and Western Blot HEK293 cells were grown in DMEM supplemented with 10% fetal calf serum and 1% penicillin/streptomycin at 37 C under 5% CO 2 atmosphere. Cells were transfected using Lipofectamine 2000 in accordance with the manufacturer's instructions (Invitrogen). Total proteins were extracted with 1% Nonidet P-40 buffer in the presence of protease inhibitors (Roche), separated with SDS-PAGE, and electrophoretically transferred onto polyvinylidene fluoride membranes (Amersham). Membranes were blocked with 5% non-fat milk for 1 hr and incubated with rat anti-Sema3c (R&D Systems, Cat# MAB1728, RRID: AB_2301533) and mouse anti-beta-Actin (Abcam, Cat# ab8226, RRID: AB_306371) antibodies overnight, followed by treatment with horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch) and ECL Plus western blotting detection reagents in accordance with the manufacturer's instructions (ThermoScientific).
Anterograde and Retrograde DiI Labeling
Brains were dissected from control and Bcl11arEmx1 mutant pups at P0 and fixed in 4% PFA. For anterograde labeling of the corticospinal and corticothalamic tracts, crystals of DiI (1,1'-dioctadecyl-3,3,3 0 ,3 0 -tetramethylindocarbocyanine perchlorate; Molecular Probes) were inserted into the somatosensory and motor cortex region. For retrograde DiI labeling of corticospinal and corticothalamic neurons, DiI crystals were placed into the cerebral peduncle and thalamus, respectively. DiI-loaded tissues were incubated in the dark at 37 C for up to 21 days to permit dye diffusion. DiI tracings were examined on 100-mm-thick vibratome sections using a BX51 fluorescence microscope (Olympus).
Cell Counts and Statistical Analysis
For each experiment, at least three control and three mutant brains were analyzed, and three to five sections per brain were quantified. For in utero electroporation experiments, nuclear counterstaining with DAPI was used to distinguish between the VZ/SVZ, IZ, and CP. In some experiments IZ and CP were subdivided into equally sized bins as indicated in the respective figures. Stained cells were counted in radial units of 500-mm width in the presumptive somatosensory cortex of anatomically matched brain sections. For proliferation experiments, cells were counted in a radial unit of 250 mm. Caspase3 staining between P4 and P6 was evaluated in radial units of 1-mm width. Cells were counted using ImageJ (v1.48, RRID: nif-0000-30467) (NIH) and Photoshop CS4 (Adobe). Statistical analysis was done with Excel 2011 (Microsoft) or SPSS Statistic 21 (IBM) software. Significance between groups was assessed using a two-tailed Student's t test (or one-way ANOVA, followed by a least significant difference [LSD] post hoc test). p values < 0.05 were considered statistically significant.
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